You are here » Home » Companies » Company Overview » Coral Laboratories Ltd

Coral Laboratories Ltd.

BSE: 524506 Sector: Health care
NSE: N.A. ISIN Code: INE683E01017
BSE 13:10 | 27 Oct 359.00 -12.15
(-3.27%)
OPEN

373.65

HIGH

373.65

LOW

353.00

NSE 05:30 | 01 Jan Coral Laboratories Ltd
OPEN 373.65
PREVIOUS CLOSE 371.15
VOLUME 3863
52-Week high 443.30
52-Week low 81.20
P/E 10.67
Mkt Cap.(Rs cr) 128
Buy Price 359.00
Buy Qty 15.00
Sell Price 364.75
Sell Qty 5.00
OPEN 373.65
CLOSE 371.15
VOLUME 3863
52-Week high 443.30
52-Week low 81.20
P/E 10.67
Mkt Cap.(Rs cr) 128
Buy Price 359.00
Buy Qty 15.00
Sell Price 364.75
Sell Qty 5.00

Coral Laboratories Ltd. (CORALLABS) - Company History

Coral Laboratories Limited has been promoted by Navin B Doshi of the DWD group. The Company is spearheaded by Kishor R Mehta as Executive Director. CLL produces various pharmaceutical formulations. To Manufacture pharmaceutical formulations like tablets,capsules the company went into public issue in March 94 at a total cost of Rs.2.5 crores. The project has been completed successfully CLL plans to expand its activities in the present premises by foraying into the sophisticated FFS (form fill and seal) technology for injections. The machinery for the said technology will be imported. The Coral group is also diversifying into housing construction and financial services for which a new company, Coral India Finance and Housing, will be incorporated. During the year 1999-2000, the company has received ISO-9002 Certification.

.